SCHEMBL21356567

SCHEMBL21356567

O=C(C=Cc1ccc(C(=O)Nc2cnc3ccccc3c2)cc1)NO

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.67
NPC1 O15118 4/20 0.65
RAB9A P51151 4/20 0.65
KDM4E B2RXH2 2/20 0.65
MITF O75030 1/20 0.65
XBP1 P17861 1/20 0.65
PAX8 Q06710 1/20 0.65
KLF5 Q13887 1/20 0.65
ALDH1A1 P00352 2/20 0.62
TRPV1 Q8NER1 10/20 0.62
SMN1; SMN2 Q16637 2/20 0.57
HDAC6 Q9UBN7 2/20 0.55
HDAC3 O15379 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC1 Q13547 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC2 Q92769 1/20 0.55
HDAC10 Q969S8 1/20 0.55
HDAC11 Q96DB2 1/20 0.55
HDAC8 Q9BY41 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19631304 1.00 KDR (0.67) KDRNPC1RAB9AKDM4EMITF
SCHEMBL19631472 0.86 KDM4E (0.67) KDRNPC1RAB9AKDM4EMITF
SCHEMBL19616459 0.85 KDR (0.81) KDRNPC1RAB9AKDM4EMITF
SCHEMBL29647749 0.85 KDR (0.81) KDRNPC1RAB9AKDM4EMITF
SCHEMBL19631486 0.85 PABPC1 (0.66) KDRNPC1RAB9AALDH1A1TRPV1
SCHEMBL21356144 0.85 PABPC1 (0.66) KDRNPC1RAB9AALDH1A1TRPV1
SCHEMBL29761200 0.85 PABPC1 (0.66) KDRNPC1RAB9AALDH1A1TRPV1
SCHEMBL5909669 0.83 KDR (0.65) KDRNPC1RAB9AKDM4EMITF
SCHEMBL5909673 0.83 KDR (0.65) KDRNPC1RAB9AKDM4EMITF
SCHEMBL5284418 0.83 TRPV1 (0.71) KDRNPC1RAB9AKDM4EMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346563-A1 HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN UNIV TAIPEI MEDICAL (TW) 2025-11-13 US disclosed
US-11427544-B2 Histone deacetylase 6 inhibitors and use thereof TAIPEI MEDICAL UNIVERSITY (TW) 2022-08-30 US disclosed
US-20220251043-A1 HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN TAIPEI MEDICAL UNIVERSITY (TW) 2022-08-11 US disclosed
EP-3458444-B1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF UNIV TAIPEI MEDICAL (TW) 2022-06-22 EP disclosed
US-20190284141-A1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF DCB-USA LLC (US) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190284141-A1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF HDAC1, HDAC11, HDAC7 KDR 4795/4885NPC1 791/4885RAB9A 3537/4885
US-20250346563-A1 HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN HDAC1, HDAC3, HDAC5 KDR 4807/4885NPC1 1951/4885RAB9A 3556/4885
US-20220251043-A1 HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN HDAC1, HDAC3, HDAC2 KDR 4819/4885NPC1 2030/4885RAB9A 3557/4885
US-11427544-B2 Histone deacetylase 6 inhibitors and use thereof HDAC1, HDAC11, HDAC7 KDR 4795/4885NPC1 791/4885RAB9A 3537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.